about
Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and CContribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infectionHost ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.Mobilizing monocytes to cross-present circulating viral antigen in chronic infection.Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infectionConserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T CellsRestored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide AnaloguesThe Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV TherapyHBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
P50
Q27472920-624C0028-EABD-4792-9F44-E55771679891Q33680736-E404657F-1839-4044-9CAD-A82F9BEA92A2Q36368397-9D212B79-2F7C-4374-AB3A-C6E0A2957C0AQ36949834-AA0D63C8-B54E-4A27-A3B7-785D5282A8BBQ37123862-4AE74657-F52A-489B-A4D8-B309098E9CA8Q37384895-F85DF271-08ED-45E4-AD51-EEA90F2B3713Q38964920-AB01AE42-AD42-4CB0-BAD3-EAD6F948828FQ42797242-E322F339-5682-4D0E-A3AD-22F2754FF325Q42995350-E87E517B-0490-4BE0-9EE2-ADFB888779FCQ43563104-A61DBED4-D61C-4511-9BC2-1BE8E8466E24Q43974120-768670DA-BFF6-40F5-9623-7931907FDA17Q44583424-516FA595-89E8-4DCD-BD58-AFB10C46A42AQ45036671-C81059AA-5695-45D8-BEE4-3AA7AF03A8F9Q45765597-219517F5-441A-45BE-B711-770F73348B71Q56881032-2CDC056E-9CD3-47BE-892D-9EF6DD4E254CQ58802756-FB5FEDED-EFFF-4870-9256-EE1BB4CDB9ECQ90723756-51E48854-C82F-4C52-A477-1E4159966BC3Q92723403-54113871-ACDE-4E58-984F-AB8104C6FCE5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carolina Boni
@ast
Carolina Boni
@en
Carolina Boni
@es
Carolina Boni
@nl
type
label
Carolina Boni
@ast
Carolina Boni
@en
Carolina Boni
@es
Carolina Boni
@nl
prefLabel
Carolina Boni
@ast
Carolina Boni
@en
Carolina Boni
@es
Carolina Boni
@nl
P106
P21
P31
P496
0000-0002-7630-5180